Institute of Professional Evaluation

Recent papers from Institute of Professional Evaluation

1. Implementation of the 3Rs Concept in Quality Control of Biologicals: Status and Prospects (Review)Safety and Risk of Pharmacotherapy · 2025
2. Cost-effectiveness of using sodium-glucose cotransporter type 2 inhibitors as a part of therapy for cardiovascular death prevention and achieving the Reduction of Cardiovascular Mortality indicator of the Healthcare Development state program in patients with chronic kidney disease and resistant hypertensionRussian Journal of Cardiology · 2025
3. The influence of ABCB1 gene polymorphisms on the development of threatened preterm labor in pregnant women of the Russian populationVrach · 2025
4. Impact of changes in the rules of Registration of medicines by the EAEU on the regulation of the turnover of medicines on its territoryResearch Journal of Pharmacy and Technology · 2024
5. Challenges Associated with Forming Generic Names for Herbal Medicinal ProductsThe Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products Regulatory Research and Medicine Evaluation · 2024
6. Requirements for the information on reference standards submitted in the dossier for biologicalsBiological Products Prevention Diagnosis Treatment · 2024
7. Possibility of using mathematical analysis methods to evaluate the potency of antibodies to hepatitis B virus surface antigen in human immunoglobulin preparationsBiological Products Prevention Diagnosis Treatment · 2023
8. Comparability assessment of the results of thiomersal quantification in adsorbed immunobiological medicinal products by colourimetry and by cold vapor atomic absorption spectrometryBiological Products Prevention Diagnosis Treatment · 2022
9. Potential factors of Helicobacter pylori resistance to clarithromycinDrug Metabolism and Personalized Therapy · 2022
10. Prospects for ion chromatography in quality assessment of biologicalsBiological Products Prevention Diagnosis Treatment · 2022
11. Temozolomide Efficacy and Metabolism: The Implicit Relevance of Nanoscale Delivery SystemsMolecules · 2022
12. WHO informal consultation on revision of guidelines on evaluation of similar biotherapeutic products, virtual meeting, 30 June – 2 July 2021Biologicals · 2022
13. Analysis of antibiotic prescriptions in patients with community-acquired pneumonia in clinical practiceClinical Microbiology and Antimicrobial Chemotherapy · 2022
14. Follistatin-Like Proteins: Structure, Functions and Biomedical ImportanceBiomedicines · 2021
15. The therapeutics, based on virus specific antibodies, for special prophylactic and current of COVID-19Infectious diseases News Opinions Training · 2021
16. Safety of Herbal Medicines: Clinical and Pharmacological AspectsSafety and Risk of Pharmacotherapy · 2020
17. Polysaccharide Vaccines. Current Approaches to Quality Assessment IssuesEpidemiology and Vaccinal Prevention · 2020
18. Effectiveness of Specific Prevention of Tick-Borne EncephalitisBiological Products Prevention Diagnosis Treatment · 2020
19. Inhibitors in the Management of Patients with Atherosclerotic Cardiovascular Diseases: Guidelines and Reimbursement IssuesRational Pharmacotherapy in Cardiology · 2020
20. First insight into the whole-genome sequence variations in Mycobacterium bovis BCG-1 (Russia) vaccine seed lots and their progeny clinical isolates from children with BCG-induced adverse eventsBMC Genomics · 2020